TV 46139Alternative Names: TV-46139
Latest Information Update: 27 Nov 2014
At a glance
- Originator Teva Pharmaceutical Industries
- Class Opioid analgesics; Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Pain
Most Recent Events
- 01 Oct 2014 Phase-I clinical trials in Pain in Israel (PO) prior to October 2014